Overview / Abstract: |
As the prevalence of eosinophilic esophagitis (EoE) continues to increase, pharmacists can play a pivotal role in its recognition, diagnosis, and recommendations for management. In this activity Dr. Gary Falk, a gastroenterologist, and pharmacists Dr. Brian Hemstreet and Dr. Hamai Tom discuss advances in EoE and the clinical implications of available and emerging therapies in long-term management. To support application to practice a downloadable pharmacy toolkit is included, comprised of two infographics on diagnosis and therapy for EoE along with publicly available resources. On May 20, 2022, the FDA approved dupilumab to treat EoE in adults and pediatric patients 12 years and older weighing at least 40 kilograms (which is about 88 pounds). |
Expiration |
Apr 29, 2023 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
1.00 contact hour |
Accreditation |
ACPE |
Presenters / Authors / Faculty |
Gary W. Falk, MD, MS; Brian A. Hemstreet, PharmD, FCCP, BCPS; Erin Hamai Tom, PharmD, APh, MBA, BCACP |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. |
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Tool Kit, Eosinophilic esophagitis, EoE, gastrointestinal, chronic disease, EoE chronic disease, EoE treatment, EoE accurate diagnosis, Gary W. Falk, MD, Brian A. Hemstreet, PharmD, Erin Hamai Tom, PharmD, budesonide, topical steroid, dupilumab, pharmacist, pharmacy, toolkit, downloadable resources Free CE CME |